IMPLICATIONS OF NEW TECHNOLOGY FOR PHARMACY EDUCATION AND PRACTICE

被引：18

作者：

BRODIE, DC

SMITH, WE

机构：

[1] UNIV CALIF SAN FRANCISCO, SCH PHARM, SAN FRANCISCO, CA 94143 USA

[2] MEM HOSP MED CTR LONG BEACH, PHARM SERV, LONG BEACH, CA 90801 USA

[3] MEM HOSP MED CTR LONG BEACH, CENT SERV, LONG BEACH, CA 90801 USA

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1985年 / 42卷 / 01期

关键词：

D O I：

10.1093/ajhp/42.1.81

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：81 / 95

页数：15

共 65 条

[1] COMMERCIAL BIOTECHNOLOGY [J].

ABELSON, PH .

[2]

ANDREWS P, 1984, AGE 0604

[3]

[Anonymous], COMMERCIAL BIOTECHNO

[4]

BARBER KRK, 1983, FEMALE PATIENT, V8, P9

[5]

BARON S, 1982, TEX REP BIOL MED, V41, P1

[6]

BARON S, 1982, TEX REP BIOL MED, V41, P411

[7] MONOCLONAL-ANTIBODIES - POWERFUL NEW TOOLS FOR THE CLINICIAN [J].

BERGER, CL ;

EDELSON, R .

[8]

BRODIE DC, 1979, AM J PHARM EDUC, V43, P427

[9]

CANAFAX DM, 1983, CLIN PHARMACY, V2, P515

[10] NEW DRUGS AND DRUG-DELIVERY SYSTEMS IN THE YEAR 2000 [J].

CHECK, WA .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1984, 41 (08) :1536-1547